Join BIOCYTOGEN at Festival Of Biologics Basel 2024

Join BIOCYTOGEN at Festival Of Biologics Basel 2024

We are pleased to announce that we will be exhibiting at one of Europe’s largest biologics events, the Festival of Biologics 2024 in Basel, taking place from October 15th to 17th. This prestigious event brings together leading basic and clinical scientists to exchange ideas and explore the latest innovations in biotechnology. We invite you to visit us and engage with industry leaders who are shaping the future of scientific discovery.

What is the Festival Of Biologics?

The Festival of Biologics serves as the premier meeting place for the life sciences community, bridging the gap between academia and industry. Covering the entire lifecycle of biologics—from discovery and development to manufacturing and commercialization—it gathers over 3,000 industry leaders, researchers, investors, and entrepreneurs from the global biotechnology sector. This prestigious event sparks valuable discussions among pharmaceutical companies, biotech firms, physicians, payers, and developers, and offers exciting talks, interactive panel discussions, and unparalleled networking opportunities.

Event Overview  

Date: October 15th-17th 9:00am-6:00pm

Venue: Hall 1, Messe Basel

Event Schedule

The Festival Of Biologics in Basel will showcase a diverse array of speakers and topics. For a comprehensive look at the daily schedule, including session times and detailed information on each presentation, please refer to the Festival Of Biologics agenda.

About BIOCYTOGEN

Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

We look forward to seeing you at the Festival Of Biologics 2024 in Basel!

Share:

Back to top
WordPress Double Opt-in by Forge12